Pricing

Marinus Pharmaceuticals Inc (MRNS)

followers ยท
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Scott N. Braunstein
Employees: 110
Web site: marinuspharma.com
5 RADNOR CORPORATE CENTER SUITE 500, 100 MATSONFORD RD, RADNOR, PA, 19087
484-801-4670
Stock Split History
Date Ratio
2020-09-23 1:4
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Marinus Pharmaceuticals, Inc. offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available